The case in front of me: HbA1c · twelve weeks · dulaglutide.
I have two candidate explanations and no way to distinguish them.
The same procedure has worked without incident several times previously, which argues against technique.
Is this recoverable, and how would I tell?
12 weeks is 84 days, and the first question about any marker is whether 84 days is long enough for it to have finished moving. HbA1c is a weighted average of the preceding ninety days or so, with the most recent thirty contributing about half of it. Against that, day 84 is about 7 per cent pre-treatment blood, so the change in front of you is a fraction of the change already in train. The second question is the denominator. Weight loss moves plasma volume, muscle mass and intake at once, and several of the markers on a routine panel are ratios with one of those three underneath them. Repeat before interpreting. A single value 84 days in, with no baseline drawn under the same conditions, is a number rather than a change — and nothing here is medical advice.
Start with a baseline. A result taken before anything started converts most later ambiguity into a simple comparison, and it cannot be obtained retrospectively.
Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.
Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.
Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.
Nothing here is medical advice. If something is out of range and you do not know why, that is a consultation rather than a research project.
Keep the full report, not the number. You will need the units and the interval later.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsThe honest position is that most people order too many analytes and too few time points, when the reverse would be more informative.
Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.
A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.
Baseline first, then a repeat under identical conditions. Everything else is secondary.
edited 8 Oct 2025 by Dr_Sara_Kuusela — reworded for clarity after a comment
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.